Please login to the form below

Not currently logged in
Email:
Password:

PM proposes Minister for Life Sciences

The UK's four life sciences trade associations have welcomed Gordon Brown's plans to appoint a Minister for Life Sciences in the next Parliament

The Association for the British Healthcare Industry (ABHI), the Association for the British Pharmaceutical Industry (ABPI), the BioIndustry Association (BIA) and the British In Vitro Diagnostics Association (BIVDA) have welcomed Prime Minister Gordon Brown's plans to appoint a Minister for Life Sciences in the next Parliament.

This announcement follows an active first year by the Office for Life Sciences, which included a number of initiatives as part of the UK 'Life Sciences Blueprint', such as the Patent Box, the Innovation Pass, the Super Cluster, the UK Innovation Investment Fund and the Strategic Health Authority Innovation Board. 

In a joint statement, all four associations said: "The UK life sciences industry applauds Gordon Brown's plans to create a Minister for the Life Sciences. It is further recognition of the vital role our industry plays in the health of the nation and in its economic wellbeing and would bolster the work of the Office for Life Sciences. Supporting the UK's science and innovation base must be a priority for any future Government. The UK must send a clear message to the rest of the world that it is - and is determined to remain - a world leader in the field of life sciences."

25th March 2010

From: Healthcare

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Onyx Health Ltd

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics